Medicines Co. (MDCO) Receives Marketing Approval from EC for Three Products

Medicines Co. (NASDAQ: MDCO) announced that the European Commission has granted marketing authorization for three of its hospital acute care products – KENGREXAL (cangrelor), ORBACTIV® (oritavancin), and RAPLIXA™ (sealant powder). These approvals ... ..

via News Feed